0001209191-16-111087.txt : 20160330 0001209191-16-111087.hdr.sgml : 20160330 20160330165414 ACCESSION NUMBER: 0001209191-16-111087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160328 FILED AS OF DATE: 20160330 DATE AS OF CHANGE: 20160330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN ANTHONY B CENTRAL INDEX KEY: 0001239241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 161540401 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKEFELLER PLAZA RM 5508 CITY: NEW YORK STATE: NY ZIP: 21264957 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-28 0 0001594864 Juno Therapeutics, Inc. JUNO 0001239241 EVNIN ANTHONY B C/O 307 WESTLAKE AVENUE N STE 300 SEATTLE WA 98109 1 0 0 0 Common Stock 2016-03-17 5 G 0 E 15000 0.00 D 50000 D Common Stock 2016-03-28 4 P 0 3946 36.2197 A 53946 D Common Stock 2016-03-28 4 P 0 4054 36.9361 A 58000 D Represents a bona fide gift of common stock; thus, there is no price associated with this transaction. This transaction was executed in multiple trades at prices ranging from $35.70 to $36.59. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $36.88 to $36.97. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Zachary D. Hale, attorney-in-fact 2016-03-30